• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ACRE

    Ares Commercial Real Estate Corporation

    Subscribe to $ACRE
    $ACRE
    Real Estate Investment Trusts
    Real Estate

    Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt products, mezzanine loans, real estate preferred equity investments, and other CRE investments, including commercial mortgage backed securities. Ares Commercial Real Estate Corporation has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Management LLC operates as the manager of the company. The company was founded in 2011 and is headquartered in New York, New York.

    IPO Year: 2012

    Exchange: NYSE

    Website: arescre.com

    Peers

    $ARDC
    $ARES
    $ARCC

    Recent Analyst Ratings for Ares Commercial Real Estate Corporation

    DatePrice TargetRatingAnalyst
    9/20/2024$7.50 → $7.00Equal Weight → Underweight
    Wells Fargo
    7/19/2024Neutral
    BTIG Research
    3/4/2024$11.00 → $7.00Buy → Underperform
    BofA Securities
    12/6/2023$10.50Neutral
    UBS
    12/5/2023Mkt Outperform → Mkt Perform
    JMP Securities
    9/13/2023$10.00Equal Weight
    Wells Fargo
    8/18/2023Outperform → Mkt Perform
    Raymond James
    4/25/2023Buy → Neutral
    BTIG Research
    3/8/2023$12.50Outperform → Mkt Perform
    Keefe Bruyette
    10/31/2022$13.00Buy
    BofA Securities
    See more ratings